Related Experiment Videos
Maroteaux-lamy syndrome: five novel mutations and their structural localization
G R Villani1, N Balzano, D Vitale
1Dipartimento di Biochimica e Biotecnologie Mediche, Facoltà di Medicina e Chirurgia, Università di Napoli 'Federico II', Via S. Pansini n 5, 80131, Napoli, Italy.
Biochimica Et Biophysica Acta
|February 26, 1999
Summary
Maroteaux-Lamy syndrome (MPS VI) is caused by arylsulfatase B deficiency. Researchers identified five new mutations in Italian patients and analyzed their structural impact on the protein, furthering understanding of this genetic disorder.
Area of Science:
- Genetics
- Biochemistry
- Molecular Biology
Background:
- Maroteaux-Lamy syndrome, also known as mucopolysaccharidosis type VI (MPS VI), is an inherited condition.
- It results from a deficiency in the lysosomal enzyme N-acetylgalactosamine-4-sulfatase (arylsulfatase B, ASB).
- Genetic heterogeneity is significant, with around 40 known molecular defects.
Purpose of the Study:
- To identify novel mutations causing Maroteaux-Lamy syndrome in Italian subjects.
- To analyze the structural consequences of these mutations on the arylsulfatase B protein.
- To contribute to understanding the molecular basis of MPS VI.
Main Methods:
- Mutation analysis in affected individuals.
- Confirmation of identified mutations using restriction enzyme analysis and ARMS.
- Three-dimensional (3-D) structure analysis of identified and previously reported mutations.
Main Results:
- Five novel mutations (S65F, P116H, R315Q, Q503X, P531R) were identified in Italian patients with MPS VI.
- These mutations were confirmed through molecular techniques.
- Structural analysis was performed on these and 22 other point mutations.
Conclusions:
- The study expands the spectrum of known molecular defects in Maroteaux-Lamy syndrome.
- Structural analysis provides insights into how these mutations may affect arylsulfatase B protein conformation and function.
- This research aids in understanding the genetic basis and potential structural impact of MPS VI mutations.